NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
New DOL Framework Prepares Workers for Human-AI Collaboration
DOL's AI Literacy Framework encourages organizations to tailor AI skills training, emphasizing human-centered approaches.
3m read -
Trump Touts AI Energy Pledge, Drug Pricing Site in State of the Union
President Donald Trump addressed AI data center power consumption, promoted TrumpRx and spotlighted a national student AI initiative during his State of the Union address.
3m read -
Navy Pushes AI from Experiments to Everyday Warfighting Functions
The Navy’s hybrid fleet hinges on a common naval lexicon and trustworthy AI woven into every intelligence function.
6m watch -
VA Launches Tech Pilot Portfolio to Accelerate Modernization
The Department of Veterans Affairs launched technology pilots to accelerate modernization by testing tools that enhance veterans services.
5m read
